(89) also demonstrated that FAP expression existed in all subtypes of malignant pleural mesothelioma, and that CD8+ T-cells targeting FAP had strong therapeutic potential in vitro and in vivo, based on reduced FAP+ tumor growth and improved survival among mice in the FAP+ model. The gene discussed is CD8A; the disease is neoplasm.